scholarly journals Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Diabetes Care ◽  
2014 ◽  
Vol 38 (3) ◽  
pp. 412-419 ◽  
Author(s):  
Robert R. Henry ◽  
Julio Rosenstock ◽  
Steven Edelman ◽  
Sunder Mudaliar ◽  
Alexandros-Georgios Chalamandaris ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Pilot Study ◽  
Sglt2 Inhibitor ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

2021 ◽  
pp. 100895
Author(s):  
Jens Christian Laursen ◽  
Niels Søndergaard-Heinrich ◽  
Joana Mendes Lopes de Melo ◽  
Bryan Haddock ◽  
Ida Kirstine Bull Rasmussen ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Crossover Trial ◽  
Acute Effects ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double‐blind, placebo‐controlled trial

2020 ◽  
Vol 8 (6) ◽  
pp. 695-704
Author(s):  
Anne‐Marie Langmach Wegeberg ◽  
Christian Stevns Hansen ◽  
Adam D Farmer ◽  
Jesper Scott Karmisholt ◽  
Asbjorn M Drewes ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Controlled Trial ◽  
Colonic Transit ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes

PLoS ONE ◽  
2015 ◽  
Vol 10 (9) ◽  
pp. e0137525 ◽  
Author(s):  
Benjamin Udoka Nwosu ◽  
Louise Maranda ◽  
Karen Cullen ◽  
Lisa Greenman ◽  
Jody Fleshman ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Metformin Therapy ◽  
Obese Youth
Sign in / Sign up

Export Citation Format

Share Document